Lowe v. Wexford Health Sources, Inc.

CourtDistrict Court, S.D. West Virginia
DecidedSeptember 20, 2021
Docket2:17-cv-02345
StatusUnknown

This text of Lowe v. Wexford Health Sources, Inc. (Lowe v. Wexford Health Sources, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lowe v. Wexford Health Sources, Inc., (S.D.W. Va. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA

CHARLESTON DIVISION

KEITH W.R. LOWE

Plaintiff,

v. CIVIL ACTION NO. 2:17-cv-02345

DR. SHERRY JOHNSON, et al.,

Defendants.

MEMORANDUM OPINION AND ORDER

Before the Court is Plaintiff’s Amended Complaint under 42 U.S.C. § 1983 against Dr. Sherri Johnson, in her individual capacity; David Ballard, former warden of Mount Olive Correctional Complex (“MOCC”); and James Rubenstein, the former Commissioner of WVDOC, in his individual and official capacities (collectively, “Defendants”).1 (ECF No. 19.) By Standing Order entered April 13, 2017, this action was referred to United States Magistrate Judge Dwane L. Tinsley for submission of proposed findings and a recommendation for disposition (“PF&R”). (ECF No. 3.) Magistrate Judge Tinsley entered his PF&R on July 28, 2021, recommending that the Defendants’ motions for summary judgment be granted and that this matter be dismissed from the docket of the court. (ECF No. 127.) On or about August 20, 2021, Plaintiff filed objections to the PF&R.2 (ECF Nos. 134, 135.) Then, on September 3, 2021, Defendant Johnson filed a

1 At this juncture, all other defendants and claims have been dismissed. (See ECF Nos. 69, 74). 2 The Court extended the deadline to object to the PF&R through August 31, 2021, and, thus Plaintiff’s objections are timely. (See ECF No. 133.) 1 Response to Plaintiff’s Objections to Proposed PF&R. (ECF No. 137.) Defendants Ballard and Rubenstein filed their response in opposition to Plaintiff’s objections on September 7, 2021. (ECF No. 138.) For the reasons discussed more fully herein, the Court OVERRULES Plaintiff’s

objections, (ECF Nos. 134, 135), and ADOPTS the PF&R. Moreover, the Court DENIES Plaintiff’s Motion for Extension of Time to Respond, (ECF No. 130), and Plaintiff’s Motion for Status Hearing, (ECF No. 128), AS MOOT. I. Background3 A detailed recitation of the extensive facts of this action can be found in the PF&R, (ECF No. 127), and therefore need not be repeated herein. The Court will provide a discussion of any relevant facts as necessary throughout this opinion to resolve Plaintiff’s objections. Plaintiff has been diagnosed with epilepsy and suffers from seizures as a result of this diagnosis. (ECF No. 19 at p. 10, ¶ 15.) While in custody at the MOCC, he was provided healthcare services by Defendant Johnson. (ECF No. 19). On or about April 2, 2015, Defendant Johnson

terminated Plaintiff’s Dilantin prescription, which he was prescribed to help manage his epilepsy. (ECF No. 19 at p. 11, ¶ 21.) Effective administration of Dilantin requires that the individual taking Dilantin undergo regular blood testing; however, this was problematic for Plaintiff, in part, because he has a “bad needle phobia”. (See ECF No. 114-2.) To eliminate the need to take regular blood draws from Plaintiff, several weeks later, Defendant Johnson prescribed Plaintiff an alternative anti-seizure medication—Keppra. (ECF No. 116-1.) Unlike Dilantin, Keppra does not require

3 For the purposes of this order, the Court treats Plaintiff’s verified Amended Complaint as the equivalent of an affidavit. Willams v. Griffin, 952 F.2d 820, 823 (4th Cir. 1991) (“[A] verified complaint is the equivalent of an opposing affidavit for summary judgment purposes when the allegations contained therein are [sworn under the penalty of perjury to be true and are] based on personal knowledge.”). 2 regular blood draws to ensure effectiveness and safety of the medication. (See ECF No. 116-1.) Plaintiff contends he did not start receiving Keppra—the alternative anti-seizure medication—until on or about April 21, 2015. (ECF Nos. 76-1, 122 at 6.) Between the discontinuation of Dilantin and Plaintiff’s receipt of the new medication,

Plaintiff alleges that he suffered at least two seizures. (ECF No. 76-1.) Plaintiff notified Ballard and Rubenstein, in writing, of the termination of his medication and his subsequent seizures. (ECF Nos. 114-4, 114-5.) As the PF&R notes, “[a]ccording to their own affidavits, because [Defendants Ballard and Rubenstein] had no medical training or expertise enabling them to properly address medical or pharmacological issues, Defendants Ballard and Rubenstein regularly deferred any inmate grievances or complaints pertaining to such treatment for handling by the contracted medical professionals employed by Wexford Health Sources, Inc.” (ECF No. 127 at 6) (citing ECF Nos. 114-4, 114-5). Plaintiff alleges that the seizures he had between the termination of Dilantin and his receipt of Keppra caused him to urinate, defecate, and sustain a head injury. (ECF No. 19 at pp. 13-14, ¶

33.) Plaintiff further claims that these seizures could have been prevented if he had received an alternative medication sooner or had been permitted to continue taking Dilantin. (ECF No. 19 at p. 14.) However, Plaintiff does not present any expert testimony from a qualified medical professional or verifiable evidence to validate this claim. Comparatively, Defendant Johnson points out that Plaintiff had a seizure while still on Dilantin and provides a proposed expert report that states their expert, Dr. Constantine Amores, reviewed 33 pages of Plaintiff’s medical records and opined that it was “reasonable” to discontinue the Dilantin prescription and to prescribe the

3 alternative medication. (ECF No. 114-1.) Again, Plaintiff does not have an expert witness, testimony, or evidence to rebut this reasonableness assertion. The PF&R thoroughly analyzes each of Defendants’ arguments that are contained in the motions for summary judgment and recommends this Court grant Defendants’ motions for

summary judgment, (ECF Nos. 114, 116), and dismiss this matter from the docket of the court. (ECF No. 127.) Plaintiff filed objections to the PF&R, (ECF Nos. 134, 135), and Defendants filed responses in opposition to Plaintiff’s objections. (ECF Nos. 137, 138.) This matter is now ripe for review by this Court. II. Legal Standard The Court is not required to review, under a de novo or any other standard, the factual or legal conclusions of the magistrate judge as to those portions of the findings or recommendation to which no objections are addressed. Thomas v. Arn, 474 U.S. 140, 150 (1985). Failure to file timely objections constitutes a waiver of de novo review and a party’s right to appeal this Court’s Order. 28 U.S.C. § 636(b)(1); see also Synder v. Ridenour, 889 F.2d 1363, 1366 (4th Cir. 1989);

United States v. Schronce, 727 F.2d 91, 94 (4th Cir. 1984). In addition, this Court need not conduct a de novo review when a party “makes general and conclusory objections that do not direct the Court to a specific error in the magistrate’s proposed findings and recommendations.” Orpiano v. Johnson, 687 F.2d 44, 47 (4th Cir. 1982). In reviewing those portions of the PF&R to which Plaintiff has objected, the Court will consider the fact that Plaintiff is acting pro se, and his pleadings will be accorded liberal construction. Estelle v. Gamble, 429 U.S. 97, 106 (1976); Loe v. Armistead, 582 F.2d 1291, 1295 (4th Cir. 1978).

4 III.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Thomas v. Arn
474 U.S. 140 (Supreme Court, 1986)
Wilson v. Seiter
501 U.S. 294 (Supreme Court, 1991)
United States v. Edward Lester Schronce, Jr.
727 F.2d 91 (Fourth Circuit, 1984)
George F. Thompson v. Potomac Electric Power Company
312 F.3d 645 (Fourth Circuit, 2002)
Ophelia De'Lonta v. Gene Johnson
708 F.3d 520 (Fourth Circuit, 2013)
Iko v. Shreve
535 F.3d 225 (Fourth Circuit, 2008)
Jean Germain v. Monica Metheny
539 F. App'x 108 (Fourth Circuit, 2013)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Samuel Jackson v. Joseph Lightsey
775 F.3d 170 (Fourth Circuit, 2014)
Tiffanie Hupp v. State Trooper Seth Cook
931 F.3d 307 (Fourth Circuit, 2019)
Bostic v. Schaefer
760 F.3d 352 (Fourth Circuit, 2014)
Bowring v. Godwin
551 F.2d 44 (Fourth Circuit, 1977)

Cite This Page — Counsel Stack

Bluebook (online)
Lowe v. Wexford Health Sources, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/lowe-v-wexford-health-sources-inc-wvsd-2021.